Cellares
Focus: Cellares is a biotechnology company specializing in automated cell therapy manufacturing technology, operating at Series C+ stage with 201-500 employees based in San Francisco. Their Cell Shuttle™ platform enables scalable, automated production of cell and gene therapies.
Profile data last refreshed 47m ago · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Employees
201-500
Open Jobs
36+1 this month
Stable — net +1 jobs in 30d
5 added, 4 removed. Backfill posture.
Should You Work at Cellares?
AI assessmentBest fit for process/manufacturing engineers seeking early-stage upside in validated cell therapy manufacturing tech; higher risk for those prioritizing near-term revenue visibility or established therapeutic programs.
Why Work Here
- Heavy hiring in Process Sciences (14 roles) and Quality Assurance (7 roles) signals aggressive platform scaling and manufacturing validation—ideal for bioprocess and GMP-focused engineers.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cellares
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.